相关实验视频
Updated: May 23, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.4K
心肌病和对DOX诱导的心肌病的简要见解
Sampat Singh Tanwar1, Sumeet Dwivedi2, Sheema Khan3
1Shri Vaishnav Vidyapeeth Vishwadvidyalaya, Indore, India.
概括
心肌病是一种心肌疾病,其原因和结果各异. 抗环素化疗,像多克索鲁比辛一样,可以引起严重的心脏毒性,需要研究预防和治疗策略.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心肌病包括心肌疾病与结构和功能异常,分类为初级或二级.
- 主要心肌病包括遗传,混合或获得的形式,呈现为扩张,过度缩或限制性模式.
- 超性心肌病是常见的,导致呼吸不全和心脏突然死亡;扩张性心肌病导致心力衰竭;限制性心肌病更为罕见.
研究的目的:
- 审查心肌病的临床挑战,重点关注由 antracycline 诱导的心脏毒性.
- 要突出治疗多克索鲁比诱导心肌病 (DIC) 的机制和局限性.
- 强调需要进一步研究化疗相关心脏功能障碍的预防和治疗干预措施.
主要方法:
- 对有关心肌病病因,诊断和治疗的现有文献的综述.
- 分析导致人环素心脏毒性的机制,包括氧化应激和线粒体损伤.
- 检查当前的治疗策略和局限性,包括德克斯拉和新兴方法.
主要成果:
- 心肌病由于各种病因和预后不佳而构成重大临床挑战.
- 人环素,特别是多克索鲁比辛,是有效的抗癌药物,但会引起严重的心脏毒性.
- doxorubicin 诱导的心肌病 (DIC) 的预后很差,目前有效的治疗方法有限.
结论:
- 心肌病,无论其来源如何,都构成了相当大的临床挑战.
- 人类环素诱导的心肌病是化疗的严重副作用,需要注意.
- 进一步研究有效的预防和治疗策略,以治疗心脏毒性,对于改善患者的结果至关重要.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
488
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
488
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
01:29Pathophysiology of Cardiac Performance
499
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
499
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:28Mechanism of Cardiac Arrhythmias
867
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
867